Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Gynecologic Oncology|January 16, 2014
Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survivalJoshua G Cohen, Arthur-Quan Tran, B J Rimel, et al.American Journal of Obstetrics and Gynecology|March 3, 2012
Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et alLinda Van Le, Amanda Jackson, Kevin Schuler, et al.Frontiers in Oncology|March 4, 2021
SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian CancerArthur-Quan Tran, Stephanie A Sullivan, Leo Li-Ying Chan, et al.Gynecologic Oncology|December 24, 2017
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phaseArthur-Quan Tran, Daniel O Erim, Stephanie A Sullivan, et al.Gynecologic Oncology|December 11, 2025
Associations between obesity and outcomes in pembrolizumab-treated endometrial cancerBryanna Patterson, Nikita Sinha, Emily Broaddus, et al.Gynecologic Oncology Reports|June 30, 2016
Tumor grade and chemotherapy response in endometrioid endometrial cancerBrittany A Davidson, Jonathan Foote, Leslie H Clark, et al.American Journal of Cancer Research|January 10, 2018
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitroHannah M Jones, Ziwei Fang, Wenchuan Sun, et al.American Journal of Cancer Research|June 12, 2018
Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitroHannah M Jones, Ziwei Fang, Wenchuan Sun, et al.American Journal of Translational Research|July 19, 2018
Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cellsGuangxu Xu, Ziwei Fang, Leslie H Clark, et al.Gynecologic Oncology|June 15, 2014
Endometrial cancer: a review and current management strategies: part II, William M Burke, James Orr, et al.Pageof 3